Professional guidance: A qualified medical professional should always be involved before starting any injectable peptide protocol
In May 2023, Novo Nordisk announced positive results from its Phase III trial, OASIS 1, which successfully achieved its primary endpoint
Patients are advised to limit or avoid alcohol consumption while taking tirzepatide
If you can take only one, the strongest evidence is for myo-inositol + D-chiro-inositol in a 40:1 ratio , taken at 4 g + 100 mg per day for at least 12 weeks
In the NY Times article, Richard DiMarchi, one of the early pioneers in GLP-1 research, states that many diseases may share the same root causes, even though we label them and treat them as distinct. I contend that virtually all chronic diseases are caused by constant metabolic disruption
While only minimal amount of apoptosis upon treatment with Ru(II)-OH or NP2 was observed, the treatment with NP4 trigger high amounts of early and late apoptotic processes (flow cytometry plots: Fig